These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 683967)

  • 1. [Use of the clomiphene test for evaluation of the functional state of the hypothalamus-pituitary gland-ovarian system in ovarian hyperandrogenia].
    Zelenetskaia VS; Dobracheva AD; Pishchulin AA; Zheldak LV; Razmadze TG
    Probl Endokrinol (Mosk); 1978; 24(4):36-41. PubMed ID: 683967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tests of the hypothalamic-pituitary-ovarian axis.
    Shaw RW
    Clin Obstet Gynaecol; 1976 Dec; 3(3):485-503. PubMed ID: 1009729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary and ovarian function in women with congenitally absent uterus.
    Ylikorkala O; Viinikka L
    Obstet Gynecol; 1979 Jan; 53(1):137-9. PubMed ID: 104214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary gonadotropins and ovarian function in adolescent dysfunctional uterine bleeding.
    Fraser IS; Michie EA; Wide L; Baird DT
    J Clin Endocrinol Metab; 1973 Sep; 37(3):407-14. PubMed ID: 4785428
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men.
    Wang CF; Lasley BL; Yen SS
    J Clin Endocrinol Metab; 1975 Jul; 41(1):41-3. PubMed ID: 1097463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.
    Pagán YL; Srouji SS; Jimenez Y; Emerson A; Gill S; Hall JE
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1309-16. PubMed ID: 16434454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of pulsatile liberation of gonadotropins in the development of amenorrhea].
    Hámori M; Szendei G; Urbancsek J
    Zentralbl Gynakol; 1987; 109(12):783-7. PubMed ID: 3115000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Stein-Leventhal syndrome: a neuropituitary disorder.
    Scaglia H; Medina M; Gual C; Cabeza M; Pérez-Palacios G
    Fertil Steril; 1976 Mar; 27(3):243-9. PubMed ID: 767160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
    Judd HL; Rigg LA; Anderson DC; Yen SS
    J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
    Couzinet B; Young J; Kujas M; Meduri G; Brailly S; Thomas JL; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4191-6. PubMed ID: 10566671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating pituitary-gonadal hormones in clomiphene-induced cycles.
    Dawood MY; Saxena BB
    Obstet Gynecol; 1978 Oct; 52(4):445-50. PubMed ID: 714327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma hormones in clomiphene citrate therapy.
    Wu CH
    Obstet Gynecol; 1977 Apr; 49(4):443-8. PubMed ID: 857209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease.
    Blankstein J; Rabinovici J; Goldenberg M; Shaley J; Mehta A; Serr DM; Mashiach S
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1164-7. PubMed ID: 3119650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of clomiphene on the restoration of ovulation in androgen-sterile rats].
    Baranov VG; Kogan ME; Propp MV; Proimina FI
    Probl Endokrinol (Mosk); 1977; 23(1):60-4. PubMed ID: 322123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
    Song J; Shen H; Li J; Huang Z; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional state of the pituitary gland-ovarian system in gonadal agenesis and dysgenesis].
    Zarubina NA; Golubeva IV; Bobrovskaia TA; Dobracheva AD; Konnova EV
    Probl Endokrinol (Mosk); 1978; 24(4):41-6. PubMed ID: 683968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Pituitary-ovarian relationships in polycystic ovarian disease.
    Baird DT; Corker CS; Fraser WM; Michie EA; Van Look PF
    J Endocrinol; 1975 Mar; 64(3):53P-54P. PubMed ID: 1133543
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypogonadotropic hypogonadism in idiopathic hemochromatosis: evidence for combined hypothalamic and pituitary involvement.
    Siminoski K; D'Costa M; Walfish PG
    J Endocrinol Invest; 1990 Nov; 13(10):849-53. PubMed ID: 2128941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.